NCT07049679

Brief Summary

The proposed study aims to fill the gap by adapting an evidence-based intervention and conducting a pilot trial to determine the new program's estimated effect sizes on occupational resilience, A1c, and diabetes-related quality of life. Developing and adapting Lifestyle Redesign (LR) for Marshallese diabetes management is significant because it would reduce health disparities in a community that is disproportionately affected by the disease, and a large number of Marshallese (currently approximately 15,000) have resided in the northwest Arkansas region since the 1980s.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2025

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 3, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

August 6, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2025

Completed
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

Same day

First QC Date

June 25, 2025

Last Update Submit

August 14, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Occupational Resilience Measure (ORM 1.0)

    a 20-item self-report assessment designed to evaluate occupational resilience, which is the capacity to persist in an occupation despite adversity

    At time of enrollment and week 15

  • Diabetes-related quality of Life (RV-DQOL)

    The primary objective of the RV-DQoL is to measure various aspects of quality of life affected by diabetes, including: Satisfaction: Assessing patient satisfaction with different aspects of their life, including time spent managing diabetes and receiving checkups, current treatment, knowledge about diabetes, body appearance, and overall life satisfaction. Impact: Evaluating the extent to which diabetes impacts daily life, including feelings of physical illness or pain related to treatment, embarrassment related to managing diabetes in public, and interference with family life. Worry: Assessing the degree of worry related to diabetes, such as passing out due to low blood sugar, changes in body appearance, and the potential for developing complications.

    At time of enrollment and week 15

  • A1C lab measure

    is a blood test that measures your average blood sugar (glucose) levels over the past two to three months. It works by measuring the amount of glucose attached to hemoglobin, a protein in your red blood cells responsible for carrying oxygen.

    screening and week 15

Study Arms (2)

Standard of Care - Group B

NO INTERVENTION

This group will not participate in the AHD Program. The group participants will continue their routine care but will be invited to all 6 sessions on managing a healthy diet run by the EFNEP team.

ActiveHeal Diabetes (AHD) Program - Group A

EXPERIMENTAL

This group will continue routine care and participate in the AHD Program. AHD Program.

Behavioral: ActiveHeal Diabetes (AHD) Program

Interventions

Biweekly phone/Zoom calls to support physical activity and dietary behavior change, focused on history, experience, benefits and adaptation

ActiveHeal Diabetes (AHD) Program - Group A

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Marshallese Adults
  • type 2 diabetes and test results (within 30 days) showing A1C greater than 6.4% or Estimated Average Glucose greater than 137 mg/dL.
  • Able (and willing) to participate in exercise, diet management, and group dancing.

You may not qualify if:

  • Comorbidities that limit participation in the specified activities (i.e., stepper exercises, dieting, and dancing).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2025

First Posted

July 3, 2025

Study Start

August 6, 2025

Primary Completion

August 6, 2025

Study Completion

August 6, 2025

Last Updated

August 19, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share